Next-Generation Obesity Drugs Likely to Focus on Multi-Action and Oral Therapies, Report Says
SEOUL, Nov. 5 (Korea Bizwire) — The next wave of obesity treatments is expected to center on multi-action drugs and oral formulations, according to a new report by global pharmaceutical research firm IQVIA, as drugmakers race to overcome the limitations of current blockbusters such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro. The two companies currently [...]










